<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29106589</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2048-7207</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Dec</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of the Pediatric Infectious Diseases Society</Title><ISOAbbreviation>J Pediatric Infect Dis Soc</ISOAbbreviation></Journal><ArticleTitle>A Multicenter Consortium to Define the Epidemiology and Outcomes of Inpatient Respiratory Viral Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients.</ArticleTitle><Pagination><StartPage>275</StartPage><EndPage>282</EndPage><MedlinePgn>275-282</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jpids/pix051</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Respiratory virus infections (RVIs) pose a threat to children undergoing hematopoietic stem cell transplantation (HSCT). In this era of sensitive molecular diagnostics, the incidence and outcome of HSCT recipients who are hospitalized with RVI (H-RVI) are not well described.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective observational cohort of pediatric HSCT recipients (between January 2010 and June 2013) was assembled from 9 US pediatric transplant centers. Their medical charts were reviewed for H-RVI events within 1 year after their transplant. An H-RVI diagnosis required respiratory signs or symptoms plus viral detection (human rhinovirus/enterovirus, human metapneumovirus, influenza, parainfluenza, coronaviruses, and/or respiratory syncytial virus). The incidence of H-RVI was calculated, and the association of baseline HSCT factors with subsequent pulmonary complications and death was assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 1560 HSCT recipients, 259 (16.6%) acquired at least 1 H-RVI within 1 year after their transplant. The median age of the patients with an H-RVI was lower than that of patients without an H-RVI (4.8 vs 7.1 years; P &lt; .001). Among the patients with a first H-RVI, 48% required some respiratory support, and 14% suffered significant pulmonary sequelae. The all-cause and attributable case-fatality rates within 3 months of H-RVI onset were 11% and 5.4%, respectively. Multivariate logistic regression revealed that H-RVI onset within 60 days of HSCT, steroid use in the 7 days before H-RVI onset, and the need for respiratory support at H-RVI onset were associated with subsequent morbidity or death.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Results of this multicenter cohort study suggest that H-RVIs are relatively common in pediatric HSCT recipients and contribute to significant morbidity and death. These data should help inform interventional studies specific to each viral pathogen.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Brian T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danziger-Isakov</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sweet</LastName><ForeName>Leigh R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Section of Infectious Diseases, Texas Children's Hospital, Baylor College of Medicine, Houston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munoz</LastName><ForeName>Flor M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Section of Infectious Diseases, Texas Children's Hospital, Baylor College of Medicine, Houston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maron</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuomanen</LastName><ForeName>Elaine</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Alistair</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Seattle Children's Research Institute, Seattle Children's Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Englund</LastName><ForeName>Janet A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Seattle Children's Research Institute, Seattle Children's Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dulek</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Monroe Carell Jr Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halasa</LastName><ForeName>Natasha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Department of Pediatrics, Monroe Carell Jr Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Children's Hospital of Pittsburgh of UPMC, Departments of Pediatrics and Surgery.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Pittsburgh School of Medicine, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michaels</LastName><ForeName>Marian G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Children's Hospital of Pittsburgh of UPMC, Departments of Pediatrics and Surgery.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Pittsburgh School of Medicine, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madan</LastName><ForeName>Rebecca Pellett</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Albert Einstein College of Medicine and Children's Hospital at Montefiore, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herold</LastName><ForeName>Betsy C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Albert Einstein College of Medicine and Children's Hospital at Montefiore, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbach</LastName><ForeName>William J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Departments of Pediatrics and Molecular Genetics and Microbiology, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Pediatric Infect Dis Soc</MedlineTA><NlmUniqueID>101586049</NlmUniqueID><ISSNLinking>2048-7193</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018380" MajorTopicYN="N">Hematopoietic Stem Cell Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012138" MajorTopicYN="N">Respiratory Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29106589</ArticleId><ArticleId IdType="pmc">PMC7107490</ArticleId><ArticleId IdType="doi">10.1093/jpids/pix051</ArticleId><ArticleId IdType="pii">3916680</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jain S Williams DJ Arnold SR, et al. ; Centers for Disease Control and Prevention EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 2015; 372:835&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4697461</ArticleId><ArticleId IdType="pubmed">25714161</ArticleId></ArticleIdList></Reference><Reference><Citation>Waghmare A, Englund JA, Boeckh M. How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation. Blood 2016; 127:2682&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4891952</ArticleId><ArticleId IdType="pubmed">26968533</ArticleId></ArticleIdList></Reference><Reference><Citation>Luj&#xe1;n-Zilbermann J Benaim E Tong X, et al. . Respiratory virus infections in pediatric hematopoietic stem cell transplantation. Clin Infect Dis 2001; 33:962&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11528566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH Jang JH Lee SH, et al. . Respiratory viral infections during the first 28 days after transplantation in pediatric hematopoietic stem cell transplant recipients. Clin Transplant 2012; 26:736&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22385011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutspardol S Essa M Richardson S, et al. . Significant transplantation-related mortality from respiratory virus infections within the first one hundred days in children after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2015; 21:1802&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110880</ArticleId><ArticleId IdType="pubmed">26117558</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA Taylor R Thielke R, et al. . Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42:377&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanning WN, Duncan CN, El-haddad A, Lehmann LE. Principles of bone marrow and stem cell trasplantation. In: Orkin SH Fishr DE Ginsburg D, et al.. Hematology and Oncology of Infancy and Childhood. Vol 1 Philadelphia, PA: Elsevier Saunders;2015: pp 254&#x2013;90.</Citation></Reference><Reference><Citation>Lo MS Lee GM Gunawardane N, et al. . The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr Transplant 2013; 17:133&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">23228170</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo S Xie H Campbell AP, et al. . Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome. Clin Infect Dis 2014; 58:1357&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001290</ArticleId><ArticleId IdType="pubmed">24599766</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo S Gooley TA Kuypers JM, et al. . Human metapneumovirus infections following hematopoietic cell transplantation: factors associated with disease progression. Clin Infect Dis 2016; 63:178&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4928387</ArticleId><ArticleId IdType="pubmed">27143659</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud C Xie H Seo S, et al. . Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients. Biol Blood Marrow Transplant 2013; 19:1220&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3752411</ArticleId><ArticleId IdType="pubmed">23680472</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan A Wang C Yang J, et al. . Symptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17:1520&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4936785</ArticleId><ArticleId IdType="pubmed">21396476</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39:1300&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15494906</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YJ Guthrie KA Waghmare A, et al. . Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease. J Infect Dis 2014; 209:1195&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969549</ArticleId><ArticleId IdType="pubmed">24368837</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo S Campbell AP Xie H, et al. . Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement. Biol Blood Marrow Transplant 2013; 19:589&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3667608</ArticleId><ArticleId IdType="pubmed">23298855</ArticleId></ArticleIdList></Reference><Reference><Citation>Milano F Campbell AP Guthrie KA, et al. . Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients. Blood 2010; 115:2088&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2837322</ArticleId><ArticleId IdType="pubmed">20042728</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>